CAC
TELA icon

Cowen and Company’s TELA Bio TELA Stock Holding History

Cowen and Company’s Portfolio TELA Stock Details TELA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-434,033
Closed -$5.55M – 726
2021
Q4 		$5.55M Buy
434,033
+41,933
+11% +$531K 0.5% 40
2021
Q3 		$5.36M Buy
392,100
+815
+0.2% +$11.4K 0.25% 44
2021
Q2 		$6.3M Sell
391,285
-10,091
-3% -$138K 0.33% 35
2021
Q1 		$5.98M Sell
401,376
-400
-0.1% -$6.02K 0.41% 27
2020
Q4 		$6.04M Sell
401,776
-7,228
-2% -$117K 0.54% 23
2020
Q3 		$6.76M Sell
409,004
-413
-0.1% -$5.8K 1.1% 14
2020
Q2 		$5.31M Buy
409,417
+3,910
+1% +$51.4K 0.88% 15
2020
Q1 		$3.17M Buy
405,507
+381,676
+1,602% +$5.16M 0.73% 28
2019
Q4 		$309K Buy
+23,831
New +$291K 0.03% 164

Other funds holding TELA

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
GPCM
Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Cowen and Company's TELA Position: Q1 2022 in Review

Cowen and Company sold out of TELA Bio (TELA) in Q1 2022, closing a stake of 434,033 shares — an estimated $5.55M sold.

Cowen and Company first reported a position in TELA in Q4 2019 and held it in 9 quarters. The position peaked at $6.76M in Q3 2020. 30 funds tracked by Wall St. Rank hold TELA as of Q1 2022.

  • Cowen and Company reported no remaining TELA Bio position as of Q1 2022 after selling out during the quarter.
  • Cowen and Company sold 434,033 TELA Bio shares in Q1 2022, an estimated $5.55M.
  • Cowen and Company first reported a position in TELA Bio in Q4 2019 and held it in 9 quarters.
  • Cowen and Company's TELA Bio position peaked at $6.76M in Q3 2020.
  • 30 funds tracked by Wall St. Rank held TELA Bio as of Q1 2022.

Based on Cowen and Company's 13F filing for Q1 2022, filed 16 May 2022.